WHO ICTRP trial
A Pharmacokinetics Study of Gerilimzumab Injection
ChiCTR-IIR-17013205 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IIR-17013205 |
|---|---|
| Public title | A Pharmacokinetics Study of Gerilimzumab Injection |
| Scientific title | Randomized, double blind, placebo-controlled, in parallel clinical study to compare pharmacokinetics profile of Phase I clinical trial testing drug to originator with a single dose of Gerilimzumab injection in healthy adult volunteers |
| Primary sponsor | Peking University People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | I (Phase I study) |
| Countries | China;China;China;China;China |
| Conditions | Rheumatoid arthritis |
| Interventions | Arm 1:Subcutaneous injection;Arm2 :Subcutaneous injection;Arm 3:Subcutaneous injection;Arm 4:Subcutaneous injection;Arm 5:Subcutaneous injection;Arm 6:Subcutaneous injection |
| Registration date | Nov 1, 2017 |
| Target size | Arm 1:4;Arm2 :12;Arm 3:12;Arm 4:12;Arm 5:12;Arm 6:6 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: